Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 2:
Embecta Corp. EMBC: This medical device company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.9% over the last 60 days.
Embecta Corp. price-consensus-chart | Embecta Corp. Quote
Embecta has a price-to-earnings ratio (P/E) of 7.97 compared with 25.13 for the S&P. The company possesses a Value Scoreof A.
Embecta Corp. pe-ratio-ttm | Embecta Corp. Quote
Blue Bird Corporation BLBD: This school bus manufacturer carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.9% over the last 60 days.
Blue Bird Corporation price-consensus-chart | Blue Bird Corporation Quote
Blue Bird Corporation has a price-to-earnings ratio (P/E) of 10.48 compared with 14.50 for the industry. The company possesses a Value Score of A.
Blue Bird Corporation pe-ratio-ttm | Blue Bird Corporation Quote
Enova International, Inc. ENVA: This technology and analytics company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% over the last 60 days.
Enova International, Inc. price-consensus-chart | Enova International, Inc. Quote
Enova International has a price-to-earnings ratio (P/E) of 11.85 compared with 14.90 for the industry. The company possesses a Value Score of A.
Enova International, Inc. pe-ratio-ttm | Enova International, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Enova International, Inc. (ENVA) : Free Stock Analysis Report
Blue Bird Corporation (BLBD) : Free Stock Analysis Report
Embecta Corp. (EMBC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.